Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?

ABSTRACT: The increasing efficacy of cancer therapeutics means that the timespan of cancer therapy administration is undergoing a transition to increasingly long-term settings. Unfortunately, chronic therapy-related adverse health events are an unintended, but not infrequent, outcome of these life-saving therapies. Historically, the cardio-oncology field has evolved as retrospective effort to understand the scope, mechanisms, and impact of treatment-related toxicities that were already impacting patients. This review explores whether current systemic approaches to detecting, reporting, tracking, and communicating AEs are better positioned to provide more proactive or concurrent information to mitigate the impact of AE's on patient health and quality of life. Because the existing tools and frameworks

SUBMITTER: Pettit SD 

PROVIDER: S-EPMC7048033 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature